Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-03 · accession 0001127602-23-003809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-07 | 2023-02-03+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.05 | -314.2K | 13.58M | -2% | -$645.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-03 | S | D | 156,383 | $2.13 | 13,733,103 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-02-06 | S | D | 157,790 | $1.98 | 13,575,313 | D | — | — |